- Feature Paper
- Article
8 Citations
5,801 Views
19 Pages
Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model
- Mustapha Najimi,
- Sébastien Michel,
- Maria M. Binda,
- Kris Gellynck,
- Nathalie Belmonte,
- Giuseppe Mazza,
- Noelia Gordillo,
- Yelena Vainilovich and
- Etienne Sokal
Accumulated experimental and clinical evidence supports the development of human allogeneic liver-derived progenitor cells (HALPCs) to treat fibro-inflammatory liver diseases. The aim of the present study was to evaluate their therapeutic effect in a...